Advertisements


We are Sorry, This Page doesn't Exist


Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost

Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost.....»»

Category: topSource: seekingalphaApr 9th, 2018

Brainstorm Health: Facebook Hospital Data, Incyte Stock, Yescarta Price

Brainstorm Health Daily: April 6, 2018 Hello and happy Friday, readers! This is Sy. Shares of biotech Incyte tumbled following a clinical trial setback for one of the company’s marquee experimental cancer.....»»

Category: europeSource: fortuneApr 6th, 2018

Roche breast cancer data could pressure Puma shares, says RBC Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall15 hr. 2 min. ago

Chinese Drugmaker"s IPO Tests a Slumping Biotech Market

A Chinese cancer drug developer is pushing ahead with an initial public offering in Hong Kong, despite a global markets rout and the recent poor performance of other biotechnology startups that have listed in the city......»»

Category: smallbizSource: wsj17 hr. 2 min. ago

The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program

Here's a roundup of top developments in the biotech space over the last 24 hours. Amid the market mayhem, no biotech or medical device companies made it to 52-week highs. Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 11) read more.....»»

Category: blogSource: benzingaOct 12th, 2018

Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO

The blockbuster public offering pegs Allogene's market value at more than $2 billion. Biotech’s red-hot IPO streak shows no signs of slowing down. In fact, on Thursd.....»»

Category: europeSource: fortuneOct 11th, 2018

Brainstorm Health: Allogene IPO, Medtronic Hack Concern, Pharmacy Gag Clause

Brainstorm Health Daily: October 11, 2018 Good afternoon, readers--This is Sy. Biotech’s red-hot IPO streak shows no signs of slowing down. In fact, on Thursday, cancer drug maker Allogene Therapeutics pulled .....»»

Category: europeSource: fortuneOct 11th, 2018

Here"s Why Viking Therapeutics Skyrocketed 33% in September

Solid phase 2 data has investors excited about the biotech's future......»»

Category: topSource: foxnewsOct 11th, 2018

Biotech firm raises $54M to hunt for cancer drugs

Gotham Therapeutics, a Manhattan-based biotech company, has received $54 million in Series A financing to advance research into a novel method of finding oncology drug candidates. The research was... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkOct 10th, 2018

Moleculin Biotech to present new WP1122 data at Society for Neuro-Oncology

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2018

Short Sellers Back Off Major Biotechs

The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased......»»

Category: blogSource: 247wallstOct 10th, 2018

This 3D printer could one day make new body parts for transplant patients

Cellink / Supplied According to data from Cleveland Clinic, 21 people in the US die waiting for an organ every day. Swedish startup Cellink has managed to find a way to 3D print tissues and organs — from skin and ears to liver and cancer. The .....»»

Category: topSource: businessinsiderOct 9th, 2018

The Daily Biotech Pulse: Affimed"s Cancer Drug Placed On Clinical Hold, Celgene"s Positive Scalp Psoriasis Trial

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 8) read more.....»»

Category: blogSource: benzingaOct 9th, 2018

Eli Lilly to present new data at ESMO showcasing cancer care advances

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2018

Nobel Prize for Cancer Immunotherapy & Biotech ETFs to Buy

Zacks.....»»

Category: topSource: redinewsOct 8th, 2018

Veracyte announces new data from multiple studies in thyroid cancer diagnosis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 7th, 2018

Why ImmunoGen, Inc. Fell 10.6% on Thursday

The volatile biotech has data coming......»»

Category: topSource: foxnewsOct 4th, 2018

Brainstorm Health: Ovarian Cancer and Aspirin, Lilly Diabetes Data, Chemistry Nobel Prize

Brainstorm Health Daily: October 4, 2018 Hippocrates used it. As did Pliny the Elder--and then, too, Galen of .....»»

Category: europeSource: fortuneOct 4th, 2018

Halozyme"s PEGPH20 data featured in Clinical Cancer Research publication

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2018

Cancer biotech Arvinas prices upsized IPO at $16, the high end of the range

Arvinas Holding a preclinical b.....»»

Category: futuresSource: nasdaqSep 26th, 2018